252 related articles for article (PubMed ID: 16341903)
1. Antineutrophil cytoplasmic antibodies in Bulgarian patients with rheumatoid arthritis: characterization and clinical associations.
Manolova I; Dantcheva M
Rheumatol Int; 2005 Dec; 26(2):107-14. PubMed ID: 16341903
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases.
Chikazawa H; Nishiya K; Matsumori A; Hashimoto K
J Clin Immunol; 2000 Jul; 20(4):279-86. PubMed ID: 10939715
[TBL] [Abstract][Full Text] [Related]
3. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations.
Manolova I; Dancheva M; Halacheva K
Rheumatol Int; 2001 Jul; 20(5):197-204. PubMed ID: 11518040
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic antibodies against myeloperoxidase, proteinase 3, elastase, cathepsin G and lactoferrin in Japanese patients with rheumatoid arthritis.
Kida I; Kobayashi S; Takeuchi K; Tsuda H; Hashimoto H; Takasaki Y
Mod Rheumatol; 2011 Feb; 21(1):43-50. PubMed ID: 20878344
[TBL] [Abstract][Full Text] [Related]
6. Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis.
Khanna D; Aggarwal A; Bhakuni DS; Dayal R; Misra R
J Rheumatol; 2003 Jun; 30(6):1248-52. PubMed ID: 12784398
[TBL] [Abstract][Full Text] [Related]
7. Antigenic specificity of anti-neutrophil cytoplasmic antibody.
Fu HL; Hsu TC; Chang CC; Tsay GJ
J Formos Med Assoc; 2001 Jan; 100(1):35-9. PubMed ID: 11265258
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Characterization and clinical correlations.
Mulder AH; Horst G; van Leeuwen MA; Limburg PC; Kallenberg CG
Arthritis Rheum; 1993 Aug; 36(8):1054-60. PubMed ID: 8343182
[TBL] [Abstract][Full Text] [Related]
9. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).
Lindgren S; Nilsson S; Nässberger L; Verbaan H; Wieslander J
J Gastroenterol Hepatol; 2000 Apr; 15(4):437-42. PubMed ID: 10824890
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence and specificity of antineutrophil cytoplasmic antibodies (ANCA) in connective tissue diseases].
Puszczewicz M; Zimmermann-Górska I; Białkowska-Puszczewicz G; Tuchocka A
Pol Arch Med Wewn; 2003 Jan; 109(1):35-41. PubMed ID: 12879764
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic antibodies in synovial fluid and in serum of patients with rheumatoid arthritis and other types of synovitis.
Afeltra A; Sebastiani GD; Galeazzi M; Caccavo D; Ferri GM; Marcolongo R; Bonomo L
J Rheumatol; 1996 Jan; 23(1):10-5. PubMed ID: 8838502
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis.
Bosch X; Llena J; Collado A; Font J; Mirapeix E; Ingelmo M; Muñoz-Gómez J; Urbano-Márquez A
J Rheumatol; 1995 Nov; 22(11):2038-45. PubMed ID: 8596141
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of autoantibodies to neutrophil granule constituents among patients with reactive arthritis, rheumatoid arthritis, and ulcerative colitis.
Locht H; Skogh T; Wiik A
Ann Rheum Dis; 2000 Nov; 59(11):898-903. PubMed ID: 11053069
[TBL] [Abstract][Full Text] [Related]
14. Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: prevalence, clinical correlates, and IgG subclass.
Cambridge G; Williams M; Leaker B; Corbett M; Smith CR
Ann Rheum Dis; 1994 Jan; 53(1):24-9. PubMed ID: 8311550
[TBL] [Abstract][Full Text] [Related]
15. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis.
Teixeira L; Mahr A; Jaureguy F; Noël LH; Nunes H; Lefort A; Barry S; Deny P; Guillevin L
Rheumatology (Oxford); 2005 Feb; 44(2):247-50. PubMed ID: 15546964
[TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.
Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K
Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211
[TBL] [Abstract][Full Text] [Related]
17. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis patients.
de Bandt M; Meyer O; Haim T; Kahn MF
Br J Rheumatol; 1996 Jan; 35(1):38-43. PubMed ID: 8624621
[TBL] [Abstract][Full Text] [Related]
18. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.
Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817
[TBL] [Abstract][Full Text] [Related]
19. Antineutrophil cytoplasm autoantibodies in patients with tuberculosis are directed against bactericidal/permeability increasing protein and are detected after treatment initiation.
Esquivel-Valerio JA; Flores-Suárez LF; Rodríguez-Amado J; Garza-Elizondo MA; Rendón A; Salinas-Carmona MC
Clin Exp Rheumatol; 2010; 28(1 Suppl 57):35-9. PubMed ID: 20412700
[TBL] [Abstract][Full Text] [Related]
20. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
Radice A; Vecchi M; Bianchi MB; Sinico RA
Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
